In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis.
AUTOR(ES)
Sahm, D F
RESUMO
Vancomycin resistance exhibited by Enterococcus faecalis isolates V583, V586, and V587 is described. The vancomycin MICs ranged from 32 to 64 micrograms/ml. Although resistant to vancomycin, the isolates were susceptible to teicoplanin (MIC, less than or equal to 0.5 micrograms/ml). Such a glycopeptide susceptibility profile has not been previously described for E. faecalis. Time kill studies showed that vancomycin resistance adversely affected the synergistic activity that vancomycin and aminoglycoside combinations usually demonstrate against enterococci. However, the ability to detect vancomycin resistance varied with the susceptibility testing method used. Whereas broth microdilution, broth macrodilution, and agar dilution methods detected resistance, disk-agar diffusion and the AutoMicrobic system Gram-Positive GPS-A susceptibility card (Vitek Systems Inc., Hazelwood, Mo.) did not. To detect vancomycin resistance reliably and establish the incidence of such E. faecalis isolates, adjustments in some susceptibility testing methods may be necessary.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=172707Documentos Relacionados
- Altered peptidoglycan composition in vancomycin-resistant Enterococcus faecalis.
- In vitro fosfomycin activity in vancomycin-resistant Enterococcus faecalis
- VanD-Type Vancomycin-Resistant Enterococcus faecium and Enterococcus faecalis
- vanE Gene Cluster of Vancomycin-Resistant Enterococcus faecalis BM4405
- The cytoplasmic peptidoglycan precursor of vancomycin-resistant Enterococcus faecalis terminates in lactate.
